Prophylactic Tributyrin Supplementation in Acute Pancreatitis

Recruiting Phase 2 Interventional Study
Acute Pancreatitis
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
92 (estimated)
Sponsor
St. Antonius Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to investigate the possible effects of tributyrin supplementation in patients with a first episode of acute pancreatitis. The main question it aims to answer is: • The effect of oral tributyrin supplementation on the plasma endotoxin level Participants will be randomized between two groups: intervention and control group. They will receive: \- three times dail…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * First episode of acute pancreatitis (AP) * Able to read and/or understand the study procedures * Able to give informed consent (or their legal representatives) * \<24 hours after diagnosis of AP * \<72 hours after onset of symptoms of AP Exclusion Criteria: * Pancreatitis du…
Contacts

Hannah Pauw, MD

0883207051

ha.pauw@antoniusziekenhuis.nl

CONTACT